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Abstract
Exosomes are 30–100-nm membrane vesicles of endocytic origin that are released after the fusion of multivesicular bodies
(MVBs) with the plasma membrane. While initial studies suggested that the role of exosomes was limited to the removal of
proteins during the maturation of reticulocytes to erythrocytes, recent studies indicate that they are produced by different
types of cells and are involved in promoting inter-cellular communication and antigen presentation. Here, we describe the
isolation and characterization of exosomes from peripheral blood of BALB/c mice infected with the reticulocyte-prone non-
lethal Plasmodium yoelii 17X strain. Importantly, proteomic analysis revealed the presence of parasite proteins in these
vesicles. Moreover, immunization of mice with purified exosomes elicited IgG antibodies capable of recognizing P. yoelii-
infected red blood cells. Furthermore, lethal challenge of immunized mice with the normocyte-prone lethal P. yoelii 17XL
strain caused a significant attenuation in the course of parasitaemia, increased survival time, and altered the cell tropism to
reticulocytes. These results were obtained also when the exosomes were isolated from a P. yoelii-infected reticulocyte
culture indicating that reticulocyte-derived exosomes carry antigens and are involved in immune modulation. Moreover,
inclusion of CpG ODN 1826 in exosome immunizations elicited IgG2a and IgG2b antibodies and promoted survival,
clearance of parasites and subsequent sterile protection of 83% of the animals challenged with P. yoelli 17XL. To our
knowledge, this is the first report of immune responses elicited by exosomes derived from reticulocytes opening new
avenues for the modulation of anti-malaria responses.
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Introduction
Exosomes are 30–100-nm membrane vesicles formed by
endocytosis of segments of the plasma membrane. The internalized
segment generates multivesicular bodies (MVBs) containing small
vesicles that are released as exosomes following fusion of the MVBs
with the plasma membrane [1]. Initially described as a reticulocyte
cargo-disposal mechanism for maturation to erythrocytes [2],
exosomes are now known to be also secreted by many different
types of cells, including dendritic cells, macrophages, B cells, and
tumor cells [1,3,4]. Pioneering studies with exosomes secreted by
Epstein-Barr virus (EBV)-transformed B-cells demonstrated stimu-
lation of T-cell in an antigen-specific manner [5]. Since, the role of
exosomesinantigen presentation andimmune modulationhasbeen
amply demonstrated in different infections including Salmonella,
Mycobacterium, and Toxoplasma where exosomes released by infected
cells contain microbial proteins [1,6]. The role of exosomes in
antigen presentation in malaria, however, has not been described.
In addition to exosomes, other vesicles termed microparticles
(MPs) circulate in blood [7]. MPs should not be confounded with
exosomes as MPs originate by budding or shedding from the
plasma membrane as opposed to fusion of the MVBs with the
plasma membrane. Moreover, MPs are heterogeneous in shape
and bigger in size (100–1000 nm) and present different protein
composition [8,9]. Of note, MPs have been described associated
with malaria pathology both in human and rodent models [10].
Indeed, production of MPs by parasitized red blood cells with
implications in malaria immune responses and inflammation has
been recently described [11,12].
Exosomes were originally described in reticulocytes where they
allow remodeling of the plasma membrane in the maturation to
erythrocytes by eliminating specific proteins [2]. Remarkably,
reticulocytes are the cells preferentially, if not exclusively, invaded
by different malaria parasites such as Plasmodium vivax [13] and the
reticulocyte-prone non-lethal Plasmodium yoelii 17X strain [14]. We
thus hypothesized that reticulocyte-derived exosomes (rex) in such
infections, in addition to their role as cargo-disposable machinery,
should contain parasite proteins involved in immune modulation.
Here, we describe the presence of parasite proteins in exosomes
obtained from experimental infections of BALB/c mice infected
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26588with P. yoelii 17X (exPy). Moreover, we show that immunization of
mice with exPy results in modulation of the immune response to P.
yoelii infection. In addition, when combined with cytosine-
phosphate-guanosine oligodeoxynucleotides (CpG-ODN), immu-
nization of mice with rexPy elicited IgG2a and IgG2b antibodies
and protected mice from a lethal challenge. This is the first report
of a role in immune modulation of reticulocyte-derived exosomes
opening new avenues in the modulation of anti-malarial responses.
Results
Peripheral blood exosomes from P. yoelii 17X infections
contain parasite proteins
To determine whether exosomes derived from malaria-infected
mice contain parasite proteins, we purified exosomes from
peripheral blood of BALB/c mice infected with P. yoelii 17X at
approximately two weeks post-infection (p.i.), when reticulocytosis
reached 60–90%. Electron microscopy (EM) analysis revealed a
homogeneous population of vesicles whose cup-shape (Figure 1A)
and size (median of 56.8 nm diameter) (Figure 1B) were
consistent with previous descriptions of exosomes [15]. To better
characterize these vesicles, they were coated on latex beads,
stained with a panel of FITC-labeled or PE-labeled antibodies
and analyzed by flow cytometry. Of note, vesicles isolated both
by sucrose cushion (Figure 1C) as well as by ultracentrifugation/
filtration (Figure 1D) display similar staining profiles for the
proteins analyzed. CD107a (Lamp1) was found in vesicles
isolated from blood of infected mice indicating that they were
originated from an internal compartment and were not plasma
membrane fragments. The presence of Lamp1 together with no
Figure 1. Characterization of exosomes from the peripheral blood of BALB/c mice infected with P. yoelii 17X. (A) Electron microscope
image of negatively stained exosomes from plasma. Scale bar represents 100 nm. (B) Histogram of exosome size distribution was measured in
ultramicrographs. X values represent the centre of an interval. (C, D) Characterization of surface markers present on blood-derived exosomes.
Exosomes isolated from blood of infected mice were coated on latex beads, labeled with antibodies and detected by FACS analysis. (C) Histograms of
representative marker of exosomes (Lamp1) and marker enriched in reticulocyte-derived exosomes (Tfrc) isolated by ultracentrifugation and sucrose-
gradient purification. (D) Representative staining markers of exosomes (Lamp1), reticulocyte-derived exosomes (Tfrc, Itga4) and exosomes derived
from T-cells (CD3f), APCs (MHC II, CD86), and platelets (CD41) performed on exosomes purified by ultracentrifugation and filtration. Histogram for the
CD40l (microparticles) and CD133 (membrane particle) are also shown. Controls (tinted histograms) were performed with isotype controls or directly
coupled secondary Abs.
doi:10.1371/journal.pone.0026588.g001
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marker CD133 [8] indicates that our preparation of vesicles are
mainly exosomes (Figure 1D). To determine whether the
exosomes can come from different origins, we analyzed the
presence of cell-specific molecules. Exosomes from infected blood
showed the presence of CD71 (Tfrc) and Itga4 (integrin a4),
molecules that were previously described in reticulocyte-derived
exosomes [16]. Moreover, low staining for Antigen presenting cell
(APC) markers class II MHC and CD86 and the platelet-specific
marker CD41 (GpIIb) [17,18] were also found on exosomes
obtained from plasma. In addition, we could not find staining for
the T-cell marker CD3f [17,19], further indicating that vesicles
obtained from these BALB/c–P. yoelii 17X infections are
exosomes mostly originating from reticulocytes.
Next, we determined the proteome of exosomes by liquid
chromatography-tandem mass spectrometry (LC-MS/MS). Re-
sults confirmed that exosomes purified from plasma of BALB/c
mice infected with P. yoelii 17X contain many of the proteins most
frequently found in exosomes such as Hsp8/Hsp90, Actb, Eno1,
Anxa2, Ywhaz, Msn, Cfl1 and Actg1 [18] (Tables S1,S2).
Moreover, a large number of proteins previously described in rex
(Hsc70, CD47, aquoporin1 and Tfrc) [20–22] were also identified
in our proteomic analysis. In contrast, no markers of MPs (CD40l)
or apoptotic vesicles (Histones) [23] were found in the 100,0006g
pellet. Remarkably, proteomic analysis revealed the presence of
several P. yoelii antigens in exosomes (Table 1, S2). These parasite
antigens included serine-repeat antigens, merozoite surface
proteins 1 and 9, enzymes, proteases, heat-shock proteins, and
hypothetical proteins. Altogether, these results showed that
peripheral blood exosomes obtained from infections of BALB/c
mice with P. yoelii 17X contain parasite proteins likely derived
from infected reticulocytes.
Table 1. P. yoelii 17X proteins identified in peripheral blood exosomes.
Accession number Description
Num. unique
peptides Num. spectra Xcorr sum*
Min. peptide
probability
PY00291 SERA 3 22 47 87,127 8,75E-11
PY00292 Papain family cysteine protease putative 18 36 70,545 3,75E-09
PY02883 merozoite surface protein 9 precursor putative 10 20 37,951 9,73E-05
PY05999 octapeptide repeat antigen 9 15 31,953 5,02E-05
PY03885 L lactate dehydrogenase 9 25 38,922 2,21E-10
PY05748 merozoite surface protein 1 precursor 9 14 33,698 7,54E-07
PY00427 3 nucleotidase/nuclease 7 14 27,502 8,52E-05
PY00293 Papain family cysteine protease putative 7 10 25,306 0,000569
PY04614 heat shock protein 60 6 8 20,313 4,49E-06
PY02351 Y13180 multicatalytic endopeptidase 5 10 19,382 3,76E-07
PY01759 hypothetical protein 3 4 8,462 1,93E-05
PY06307 hypothetical protein 3 6 11,238 1,98E-11
PY03639 cell division cycle protein 48 homolog 3 4 11,588 0,000967
PY04190 proteasome subunit alpha Type 6 B 3 5 8,93 4,95E-05
PY03212 proteasome beta subunit putative 3 3 11,273 1,32E-05
PY00275 hypothetical protein 2 3 7,002 0,000364
PY06203 blood stage membrane protein Ag 1 2 3 6,878 0,000256
PY03709 Fructose bisphosphate aldolase class I 2 3 5,899 0,000107
PY03625 secreted blood stage antigen pAg 3 2 5 7,153 0,000172
PY06158 heat shock protein 70 2 5 7,282 3,55E-06
PY01014 retinitis pigmentosa GTPase regulator like 2 4 9,099 2,83E-06
PY06644 enolase 2 2 7,82 0,000551
PY00267 proteasome subunit alpha type 1 2 4 6,468 2,06E-05
PY03280 glyceraldehyde 3 phosphate dehydrogenase 2 2 6,064 1,14E-06
PY00622 rhoptry associated protein 1 1 2 3,592 3,04E-05
PY06837 putative T complex protein beta subunit 1 1 3,733 9,08E-05
PY06834 yir4 protein 1 1 3,588 0,00064
PY06423 hypothetical protein 1 1 4,281 0,000742
PY06767 proteosome PSMB5/8 protein 1 2 4,167 1,31E-07
PY04294 hypothetical protein 1 2 3,763 0,000269
PY05295 hypothetical protein 1 2 4,502 5,97E-05
PY03834 AhpC/TSA family putative 1 2 5,318 1,52E-12
*Xcorr sum – Sum of the cross-correlation scores of individual peptides from each identified protein.
doi:10.1371/journal.pone.0026588.t001
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yoelii 17X infections elicits parasite-specific immune
humoral responses and modulates the course of
infection upon lethal challenge
To investigate whether peripheral blood exosomes derived from
Plasmodium-infected mice could induce parasite-specific immune
responses, we immunized mice with exosomes obtained from mice
infected with the non-lethal P. yoelii 17X strain (exPy) and non-
infected animals (exC) at days 0 and 20. Twenty days after the
second immunization, sera were tested by immunofluorescence
(IFA) for the presence of anti-P. yoelii antibodies. As shown in
Figure 2A, immunizations with exPy elicited IgG antibodies
capable of specifically recognizing infected RBCs. To further
evaluate these immune responses, mice immunized with exC and
exPy were challenged twenty days later with 5610
5–10
6 P. yoelii
17XL lethal parasites. Daily examination of the animals and blood
smears by Giemsa staining revealed an attenuation in the course of
parasitaemia (Figure 2B) and higher survival times (Figure 2C)
only in mice immunized with exPy. In addition, these mice had a
significant increase of reticulocytosis (from 1–2% up to 65%) as
well as a change in the parasite’s cell tropism to reticulocytes
(Figure 2D). This change in cell tropism does not appear to be
simply the result of an increase in reticulocytosis as the percentage
of circulating normocytes did not fall below 45%; yet, close to 90%
of infected cells were reticulocytes. More importantly, these results
demonstrated that peripheral blood exosomes in this rodent
malaria model induced immune responses which modulated the
course of infection.
Reticulocyte-derived exosomes from infections are
responsible for immune modulation, reticulocytosis and
change of cell-tropism
Exosomes obtained from the blood of BALB/c mice infected
with P. yoelii 17X are likely to be originated from reticulocytes; yet,
exosomes from other cells capable of antigen presentation, such as
dendritic cells could contribute to the final pool of exosomes. To
exclude this possibility, isolated reticulocytes from blood of P. yoelii-
infected mice were cultured for 24 hours and exosomes purified
from supernatants by ultracentrifugation and filtration. Analysis of
vesicles released by these cells by EM confirmed their purity and
Figure 2. Exosomes from blood of P. yoelii 17X-infected mice modulate the course of P. yoelii 17XL infection. (A) Humoral IgG response
after exosomal immunization of BALB/c mice. Bright-field and fluorescence image projections of immune sera recognizing 17XL-pRBCs. The images
correspond to sera of representative mice. One non-immunized (NI) mouse, one mouse immunized with exosomes from control animals (exC) and
two mice immunized with exosomes from mice infected with the P. yoelii17X non-lethal strain (exPy). Staining for mouse IgG (green) and DNA (blue)
is shown. Scale bar represents 5 mm. (B) Time-course parasitaemia (mean6SD), (C) survival curve, (D) reticulocytosis (right axis, dotted line) and
percentages of infected reticulocytes (left axis, continuous line) after 5610
5–10
6 P. yoelii 17XL infections of groups of BALB/c mice previously
immunized with exosomes from control animals (exC) (n=6) and exosomes from mice infected with the P. yoelii 17X non-lethal strain (exPy) (n=6).
Non-immunized (NI) mice (n=4) were untreated. Data correspond to 3 independent experiments. (B) P. yoelii 17X mean peak level of parasitemia is
50.3%61.6% for NI, 51.77%61.02% for exC and 39.14%62.17% for exPy. The reduction was evaluated by analysis of variance and was statistically
significant (P,0.001). (C) Differences in the survival curves between NI and exPy (P,0.05) are statistically significant (Log-rank (Mantel-Cox Test)).
doi:10.1371/journal.pone.0026588.g002
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(Figure 3A). Moreover, flow cytometry analysis of rex bound to
aldehyde/sulfate beads revealed the expression in the surface of
Lamp1, Tfrc, and Itga4 markers but not of MHC II, CD3f or
CD41, confirming their origin from reticulocytes (Figure 3B). In
vitro-purified rex from infections (rexPy) or from anemic mice
(rexC) [21] were then used to immunize new groups of mice at 20-
day intervals with two i.v. doses of 5 mgo frexPy or rexC.
Nonimmunized mice (NI) were untreated. Twenty days after the
second immunization, all mice were infected with 5610
5 P. yoelii
17XL lethal parasites. Noticeably, we observed the same results as
those observed in immunizations with exosomes from peripheral
blood, namely higher survival times, increase in reticulocytosis
(from 1–2% up to 60%) and infection preference for reticulocytes
in mice immunized with exPy (Figure S1). Thus, rex from
infections contain parasite proteins and are involved in modulation
of immune responses upon infection.
Immunization with rex combined with CpG-ODN elicits
protective immune responses
CpG oligodeoxynucleotide (CPG-ODN) is a potent immunos-
timulator proving beneficial in protection against rodent malaria
[24]. We thus tested the immune enhancement effect of CpG-
ODN on immunization with rex. To do so, BALB/c mice were
immunized subcutaneously (s.c.) with 10 mgo frexCo rrexPy
combined with 10 mg CpG-ODN. Twenty days after the first
immunization, mice were boosted s.c. with 5 mg of exosomes and
forty days later sera from immunized mice were tested by IFA and
ELISA for the presence of antibodies against P. yoelii. As shown in
Figure 4, immunizations with rexPy, but not with rexCo r
nonimmunized mice, elicited IgG antibodies recognizing infected
RBCs (Figure 4A). In addition, ELISA analysis demonstrated that
elicited antibodies were predominantly of the IgG2a and IgG2b
isotypes with no detected differences in the levels of IgG3 and IgM
(Figure 4C).
Next, immunization with rexPy in combination with CpG-
ODN was tested for the ability to protect mice against a lethal
challenge with P. yoelii 17XL. Significantly, 83% of the mice
immunized with rexPy survived to a lethal infection (Figure 5A)
showing concomitantly reticulocytosis (Figure 5D) and a change
of cell-tropism to reticulocytes (Figure 5C). Of importance, mice
which survived the primary infection showed a complete
clearance of infection (Figure 5B) and remained immunopro-
tected, showing no detectable parasitaemia by Giemsa smears,
after re-challenges with P. yoelii 17XL at days 74, 116, and 156
post first infection.
Discussion
Reticulocyte-derived exosomes function as a cargo-disposal
machinery of unwanted proteins and molecules in the maturation
of reticulocytes to erythrocytes [2]. Noticeably, malaria parasites
such as P. vivax and the P. yoelii 17X strain predominantly, if not
exclusively, infect reticulocytes. Here, we describe for what we
believe is the first time, that rex from experimental infection of
BALB/c mice with the P. yoelii 17X strain contain parasite proteins
and that in addition to their cargo-disposable role in differentiation
to erythrocytes, rex have a role in modulating immune responses.
The function of rex has been less explored than the one of
exosomes derived from antigen-presenting cells, B cells, or tumor
cells. In fact, different studies have identified proteins associated
with these vesicles [25] and this has been recently confirmed and
expanded in a proteomic analysis of rex from rats [26]. Our
proteomic data from exosomes isolated from blood of P. yoelii 17X-
infected mice revealed the presence of proteins previously
described in rex such as Hsc70, CD47, aquoporin1 and Tfrc
[20,22]. Moreover, we identified the Na
+-independent neutral
aminoacid transporter LAT-1 [27], a function that was originally
described in rex [28]. Remarkably, our proteomic data also
revealed the presence of 31 parasite proteins within or associated
with exosomes obtained from reticulocyte-enriched blood of
infected animals. These proteins include several antigens such as
merozoite surface proteins 1 and 9, as well as blood stage surface
antigens, a rhoptry-associated protein and a variant Yir protein. In
addition, we identified 6 hypothetical proteins, 3 of them having
GO annotations related to binding (PY06307), pathogenesis
(PY06423), and immune response/antigen processing presentation
(PY05295). Moreover, we found 9 enzymes related to proteolysis
and metabolic processes. The function of these enzymes is yet to
be determined but it is worth recalling that some of them seem to
have moonlight functions in malaria [29–32]. In fact, we identified
enolase (PY06644) which has been found in different locations
suggesting non-glycolytic functions of this enzyme [33] and which
upon immunization as a recombinant protein partially protects
mice against P. yoelii [33]. While proteomic analysis of rexPy, per se,
remains to be determined, this data unequivocally demonstrates
the presence of malaria proteins in exosomes derived from
peripheral blood in this reticulocyte-prone rodent malaria model.
Peripheral blood contains other type of vesicles termed
microparticles (MPs) which have been described in malaria
infections both in humans and animal models. Thus, MPs from
platelets bind to erythrocytes transferring platelet antigens which
are postulated to facilitate cytoadherence to brain tissues leading to
cerebral malaria [34]. In addition, MPs have also been recently
Figure 3. Characterization of exosomes isolated from supernatants of in vitro cultured P. yoelii 17X-infected reticulocytes. (A)E M
image of negatively stained reticulocyte-derived exosomes. Scale bar represents 200 nm. (B) Characterization of surface markers present on
reticulocyte-derived exosomes by FACS analysis. A total of 5 mg exosomes prepared from reticulocytes infected with P. yoelii 17X were coated on
latex beads and labeled with Abs detectable by FACS analysis. Histograms of representative stainings for different vesicle markers are shown.
Controls (tinted histograms) were performed with isotype controls or directly coupled secondary Abs.
doi:10.1371/journal.pone.0026588.g003
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have been associated with acute vivax malaria symptoms [35].
Moreover, in rodent models, MPs derived from malaria infected
RBCs have been recently shown to lead to inflammation through
macrophage activation [11]. Noticeably, if shedding of these
vesicles occurs during P. yoelii 17X infections, they did not
contribute to our results since MPs were discarded during our
exosome preparation (pellet after 15,0006g centrifugation, see
methods). Moreover, flow cytometry revealed no significant
amounts of CD40l, a MP marker, in our vesicle preparations. In
addition, EM analysis allowed us to check for purity of our isolated
exosomes thus discarding any preparation containing contamina-
tion with particles that differ from the cup-shape and size reported
for exosomes.
Immunizations of BALB/c mice with exosomes derived from
peripheral blood or from rex purified from in vitro cultures from
infections, elicited IgG antibodies capable of recognizing P. yoelii-
infected RBCs, induced reticulocytosis and changed the cell-
tropism to reticulocytes of the normocyte-prone lethal P. yoelii
17XL strain upon infection. Moreover, when combined with
CpG-ODN, immunizations with rexPy obtained from reticulocyte
in vitro culture elicited the same responses as above in addition to
conferring complete and long lasting protection in close to 85% of
the mice tested. Of note, antibody responses in this lethal strain of
P. yoelii are mainly suppressed during infections [36]; yet, these
immunizations elicited IgG2a antibodies capable of recognizing P.
yoelii-infected RBCs. This humoral response is likely associated
with protection since it has been described that passive transfer of
the IgG2a fraction of hyperimmune plasma can modulate
parasitaemias of BALB/c mice infected with P. yoelii 17XL [37].
Remarkably, reticulocytosis, change of cell-tropism and protection
mediated by IgG2a antibodies were reported upon immunizations
of BALB/c mice with the P. yoelii 235-kDA antigen [38] and with
the P. yoelii MSP8 protein [39]. Moreover, in this latter study,
genome-wide global transcriptional analysis revealed the presence
of up-regulated genes coding for parasite antigens also identified in
our proteomic analysis such as MSP1, MSP9, rhopthry-associated
proteins and blood stage surface antigens (pAgI and pAg3) [39].
Protection in all these reports seems depending on elicitation of
IgG2a antibodies that putatively block entrance into mature red
blood cells and which, upon infections with the lethal strain, would
favor the survival of parasites entering reticulocytes. In turn, it is
tempting to speculate that infected reticulocytes should release rex
containing parasite proteins which act in inter-cellular communi-
cation and antigen presentation, thus facilitating reticulocytosis
and the mounting of a protective and long-lasting immune
Figure 4. Humoral response induced by immunization of BALB/c mice with reticulocyte-derived exosomes. Humoral response after
immunization of BALB/c mice with exosomes plus CpGODN-1826. (A) IgG responses against P. yoelii-infected RBCs. Bright-field and fluorescence
image projection of immune sera recognizing 17XL-pRBCs. Staining for mouse IgG (green) and DNA (blue) is shown. NI, nonimmunized mice sera;
rexC, sera from mice immunized with reticulocyte-derived exosomes; rexPy, sera from two different mice immunized with P. yoelii-infected
reticulocyte-derived exosomes (B,C) Antibody responses induced by immunization detected by ELISA against P. yoelii antigen. (B) IgG response in
immunized mice. Data show results with serial dilution of pooled sera (n=6/group), corresponding to 3 independent experiments collected 20 days
after the second immunization. (C) Antibody isotype response in pooled sera (n=6) of mice immunized with exosomes. Sera were diluted 1:50 before
use. Data were evaluated by analysis of variance versus NI (**P,0.01 and ***P,0.001) (Tukey post hoc test).
doi:10.1371/journal.pone.0026588.g004
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remains to be demonstrated.
To our knowledge, the results presented here provide the first
description of exosomes, not MPs, containing malaria proteins.
Moreover, our study also shows that, when combined with CpG-
ODN, rex from infections have the capacity of elicitation of
protective and long-lasting immune responses against lethal
infections in this rodent malaria model. While further experimen-
tation is required to determine the exact role of rex during
infections, rex represent a new player in immune response to
malaria that could also be used as a vaccine tool against infections.
Materials and Methods
Ethics statement
All the animal studies were performed at the animal facilities of
Hospital Clinic in Barcelona in accordance with guidelines and
protocols approved by the Ethics Committee for Animal
Experimentation of the University of Barcelona CEEA-UB.
Mice and parasites
Female BALB/c mice, 6 to 8 weeks of age, were used
throughout the study. The P. yoelii 17XL (lethal) and 17X (non-
lethal) cloned lines were originally obtained from MR4 (http://
www.mr4.org/). Infections were initiated by intraperitoneal (i.p.)
injection of 10
5–10
6 pRBCs from the tail blood of donor mice at
5–10% parasitaemia. Parasitaemia was monitored by Giemsa
staining of blood smears calculating the percentage of pRBCs over
total RBCs in three optical fields of approximately 300 RBCs.
Reticulocytosis was induced by phlebotomy as previously
described [21]. Blood was collected by cardiac puncture in
anesthetized mice. Brilliant Cresyl Blue (BCB)-Giemsa staining
was used to detect reticulocytes [40]. Briefly, five ml of mouse
blood was mixed with an equal volume of 1% BCB in 0.65%
sodium chloride and incubated at room temperature (RT) for
20 min. After incubation, smears were prepared and left to air dry.
After fixation with methanol, the smears were counterstained with
Giemsa. Percentage of reticulocytes over total RBCs was counted
in different optical fields with, at least, 1000 RBCs.
Purification of reticulocytes
Reticulocytes were obtained from mice blood collected in
EDTA. We have used blood of BALB/c anemic mice and of mice
infected with P. yoelii 17X strain at 20–30% parasitaemia. To
isolate the reticulocytes, blood was centrifuged at 10006g for
20 min. After two washes in phosphate-buffered saline (PBS),
reticulocytes were purified by layering them on top of a Percoll/
NaCl density gradient as previously described [21,41]. Briefly,
Figure 5. Immunization with exosomes from 17X-infected reticulocytes plus CpGODN-1826 protect mice from P. yoelii 17XL
infection. (A) Survival curve, (B) time-course parasitaemia (mean6SD), (C) percentages of infected reticulocytes and (D) reticulocytosis after 5610
5
P. yoelii 17XL infections of groups of BALB/c mice previously immunized subcutaneously (s.c.) with CpG-ODN plus exosomes from control
reticulocytes (rexC) (n=6) or exosomes from reticulocytes infected with the P. yoelii 17X non-lethal strain (rexPy) (n=6). Non-immunized (NI) mice
(n=6) were untreated. Data correspond to 3 independent experiments. (A) Differences in the survival curves between NI, rexC and rexPy (P,0.01) are
statistically significant (Log-rank (Mantel-Cox Test).
doi:10.1371/journal.pone.0026588.g005
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15 mL tubes and 2 mL of 1.058 g/mL Percoll were layered over.
Thereafter, 2 mL of blood diluted in PBS to a final hematocrit of
50% were layered on top of each tube. Tubes were centrifuged at
2506g for 30 minutes at 4uC. Reticulocytes were collected from
the interface of the two Percoll layers and washed twice with PBS.
We routinely obtained 763610
7 reticulocytes per uninfected mice
and 3.660.6610
8 reticulocytes per P. yoelii 17X-infected mice.
Purified reticulocytes were cultured for 24 h at 37uC in DMEM,
supplemented with 5 mM glutamine, 5 mM adenosine, 5 mM
inosine, 5% fetal calf serum, 50 U/mL penicillin, and 50 mg/mL
streptomycin at 1–3% hematocrit. To remove exogenous
exosomes in the culture medium, the fetal calf serum was
precentrifuged (100,0006g overnight) (o.n.).
Exosomes
Exosomes were purified from the plasma of uninfected mice or
mice infected with P. yoelii 17X by sequential centrifugations at
5006g for 30 min, 15,0006g for 45 min and 100,0006g for 2 h at
4uC (adapted from [17]). The final pellet was resuspended in PBS,
filtered through a 0.22-mm membrane, and centrifuged at
100,0006g for 2 h at 4uC. The pellets were resuspended in PBS,
and the protein content was determined by Bradford assay.
Usually, we are able to obtain the equivalent of 5–15 mgo f
proteins in exosomes per ml of blood (7.862.4/uninfected mice,
12.761.9/P. yoelii 17X mice). Routinely, exosomes purity was
assessed by ME analysis.
Exosomes from supernatant of culture were obtained with the
same differential centrifugation method.
For some applications, exosomes were loaded in a 30% sucrose
cushion (adapted from [15]). Briefly, exosome pellet from first
centrifugation at 100,0006g was resuspended in 6 ml PBS and
loaded on top of 1 ml sucrose/D2O solution (20 mM Tris, 30%
sucrose, pH 7.4). Samples were centrifuged in a swinging bucket
rotor at 100,0006g for 75 min. Approximately 0.75 ml of the
cushion containing exosomes was collected, diluted with PBS and
centrifuged at 100,0006g for 90 min. Washed exosomes were
then resuspended in PBS and protein content was measured using
Bradford assay.
Electron microscopy
Electron microscope analysis was performed with exosomes
fixed in 2% paraformaldehyde (PFA) o.n. at 4uC. Fixed exosomes
were deposited onto formvar grids for 20 min. Grids were then
fixed in glutaraldehyde 1% for 5 min, washed in distilled water
and negatively stained for 5 min with a solution of uranyl-oxalate
(pH=7) and for 10 min at 4uC with uranyl acetate(4%)-methyl
cellulose (2%). After thoroughly drying, grids were observed with a
JEOL 1010 transmission electron microscope. Micrographs were
used to quantify the diameter of exosomes.
Flow cytometry
Five micrograms of purified exosomes were incubated with
10 mlo f4 mm-diameter aldehyde/sulfate beads (4-mm beads,
Invitrogen) for 15 min at room temperature (RT). PBS was added
to a final volume of 1 ml and exosome-beads were incubated with
rotation overnight at 4uC. After adsorbing exosomes, beads were
subjected to glycine (100 mM final for 30 min at RT), followed by
the addition of 0.5% BSA in PBS to saturate any remaining free
binding sites on the beads. Coated beads were incubated with
different antibodies (some directly conjugated to fluorescent dyes)
diluted in PBS/0.5% BSA 30 min at 4uC. After washing, samples
were incubated as needed with fluorescent-labeled secondary
antibodies diluted in PBS/0.5% BSA for 30 min at 4uC. Samples
were analyzed by flow cytometry using a FACSCanto instrument.
A minimum of 5610
5 single beads per sample was examined.
Proteomic analysis of exosomes
Exosomal preparations were dissolved in 8 M urea 0.4 M
NH4HCO3, reduced with 5 mM dithiothreitol for 15 min at
50uC, alkylated with 10 mM iodoacetamide for 30 min, at room
temperature, and the reaction was diluted to obtain a final
concentration of 1 M urea. After digestion with trypsin for 16 h,
samples were desalted using POROS R2 ziptips [42], redissolved
in 0.1% formic acid (FA), loaded in a strong-cation exchange trap
column (5 mL, Optimized Technologies) and eluted by injecting
increasing concentrations of NaCl (0, 25, 50, 100, 200, and
500 mM NaCl in 0.5% FA/2% acetonitrile (ACN)) using the
autosampler, which is part of the 1D Plus nanoHPLC system
(Eksigent). Eluted peptides were trapped and washed (0.5% FA in
2% ACN) in a laboratory-made C18 column (1 cm, 75 mm,
Phenomenex Luna C18, 5 mm); separation was achieved in a
capillary C18 column (20 cm, 75 mm, Phenomenex Luna C18,
5 mm), using a linear acetonitrile (ACN) gradient of 5–40% B
solvent over 100 min (solvent A: 5% ACN/0.1% FA, solvent B:
80% ACN/0.1% FA). Peptides were analyzed online on a LTQ
XL/ETD (Thermo Fisher Scientific) mass spectrometer equipped
with a Triversa Nanomate (Advion) nanospray source. Full scan
MS spectra were collected from 400–1700 m/z range and the ten
most intense ions were selected for fragmentation twice, before
dynamically excluding for 1 min. MS/MS spectra were converted
to DTA files and submitted to database search using Sequest. The
search parameters were: (i) full tryptic digestion with 1 missed
cleavage site allowed; (ii) 2 Da of peptide mass tolerance; and (iii)
methionine oxidation and cysteine carbamidomethylation as
variable and static modifications, respectively. The database
(129,706 total sequences) was built with the forward and reverse
sequences of P. yoelii v5.5 (http://plasmodb.org), in addition to
possible murine (IPI mouse v3.58) and human (keratins derived
from IPI human v3.58) contaminant sequences downloaded from
http://www.ebi.ac.uk/IPI/IPIhelp.html. Data were filtered with
DCn$0.05, peptide probability #0.05 and Xcorr $1.5, 2.4 and
3.2 for 1+,2 +, and 3+ charged peptides, respectively. After
assembling the peptides into proteins and redundant proteins into
protein groups, the dataset was further filtered with Xcorr sum
(sum of Xcorr of unique peptides for each protein) $3.5 to obtain
a false-discovery rate of 0.8% at protein level.
Immunizations and challenge
For immunizations, mice were injected intravenously with two
doses of 5 mg of exosomes obtained by ultracentrifugation and
filtration and resuspended in PBS at days 0 and 20. Non-
immunized mice were untreated. Endotoxin level of exosomes was
,0.005EU/mg (determined by kinetic chromogenic LAL assay,
Genescript). Immunized animals were challenged twenty days
after the second immunization with 5610
5–10
6 P. yoelii 17XL
parasites, and parasitaemia and reticulocytosis were followed daily
using Giemsa-stained blood smears.
For CpG immunizations, mice were injected subcutaneouslly
(s.c.) with 10 mg of exosomes and 10 mg CpG ODN-1826.
Endotoxin level of exosomes was ,0.005EU/mg (determined by
kinetic chromogenic LAL assay, Genescript). Twenty days after,
mice were immunized with 5 mg of exosomes. Twenty days after
the second immunization, mice were infected with 5610
5 P. yoelii
17XL. Surviving animals were re-infected three times with P. yoelii
17XL at days 74, 116 and 156 after the first infection.
Parasitaemia was followed using Giemsa-stained blood smears.
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Humoral responses elicited by exosomes were studied by
immunofluorescence and ELISA using mouse sera collected 20
days after immunizations and tested for parasite recognition. IFA
assays were performed on P. yoelii 17XL-infected blood smears
fixed with cold methanol for 2 min and air-dried before blocking
with 5% BSA/PBS for 30 min at room temperature (RT). Slides
were incubated with mouse sera diluted 1/10 in 0.5% BSA/PBS
o.n. at 4uC followed by incubation for 1 h at RT. Reactive IgGs
were detected using an anti-mouse IgG antibody conjugated to
Alexa Fluor 488 (Invitrogen) at 1:200 dilution for 1 h at RT. After
washing, nuclei were stained with DAPI (Invitrogen, 5 mg/mL)
for 7 min at RT. Sera recognizing pRBCs were imaged for bright
field and fluorescence using a Leica SP5 microscope fitted with an
inverted 636oil objective. Sera from control non-immunized mice
and mice immunized with exosomes from uninfected animals were
used as negative controls.
Serum antibody levels were determined by an enzyme-linked
immunosorbent assay (ELISA) against P. yoelii antigen, with pooled
sera (n=6 mice per group). MaxiSorb immunoplates (Nunc) were
coated with 200 ng of parasite antigen, obtained as described [43],
in carbonate-bicarbonate buffer pH 9.6, overnight at 4uC. Wells
were blocked with 100 ml 5% BSA in coating buffer at 37uC for
3 h. After four washes with 0.05% Tween in PBS, two-fold serial
dilutions of serum samples were added in 1% BSA in PBS. After
incubation for 1 h at 37uC, wells were washed and incubated with
peroxidase-conjugated anti-mouse IgG. For isotype analysis bound
antibodies were detected with peroxidase conjugated anti-mouse
(IgG1, IgG2a, IgG2b, IgG3, or IgM) antibodies (Abcam). After
incubation for 1 h, wells were washed and incubated with 50 ml
TMB substrate (Pierce) for 15 min. The reaction was stopped with
50 ml 1N sulfuric acid per plate well. Absorbance was measured at
450 nm.
Supporting Information
Figure S1 Immunization with exosomes from 17X-
infected reticulocytes modulated the course of P. yoelii
17XL infection. (A) Survival curve, (B) time-course parasitaemia
(mean6SD), (C) percentages of infected reticulocytes and (D)
reticulocytosis after 5610
5 P. yoelii 17XL infections of groups of
BALB/c mice previously immunized intravenously (i.v.) with 5 mg
exosomes from control reticulocytes (rexC) (n=5) or 5 mgo f
exosomes from reticulocytes infected with the P. yoelii 17X non-
lethal strain (rexPy) (n=5). Non-immunized (NI) mice (n=5) were
untreated. Data correspond to 2 independent experiments. (A)
Differences in the survival curves between NI and rexPy (P,0.05)
are statistically significant (Log-rank (Mantel-Cox Test).
(TIF)
Table S1 Mouse proteins identified in exosomes derived from
mice infected with non-lethal strain of Plasmodium yoelii 17X.
(DOC)
Table S2 Detailed information about peptide Identification of
proteins from exosomes derived from mice infected with non-
lethal strain of Plasmodium yoelii 17X.
(XLS)
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